HCT - HOLISTA COLLTECH LIMITED

[nipper]

Still around ... their blurb is that Holista Colltech Ltd (HCT) is a research driven biotech company and is the result to the merger of Holista Biotech Sdn Bhd and Colltech Australia Ltd.

Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first class natural ingredients, wellness product and leads in research on herbs and food ingredients. Holista researches, develops, manufactures and markets health style products.

Highlights from the Quarterly: 

• Quarterly sales receipts hit a fresh high of $2.8m (+55.4% over pcp) 
• Operating cash flow improved despite step up in investments to build inventory to protect against inflation and supply chain disruptions 
• 1HFY22 revenue expected to be around 26% higher than last year at $4.5m (subject to final audit) 
• The largest Holista business, Health Supplements, was a standout with June quarter sales up >38% pcp 
• Positive full year outlook with multiple growth opportunities (e.g., new product innovations and further potential sales to Berjaya Group of companies)

Holista cash and cash equivalent holdings at the end of the quarter was $0.7 million, a decline over 1QFY22 due to debt repayments and the large investment in inventory. Operating cash outflow in the June quarter was $117,000, which is less than half that of the pcp and QoQ when outflow reached $372,000 and $354,000, respectively.

Market cap $12 million.